Andrea Wang-Gillam
9PUBLICATIONS
94CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 24, 2025
Neoadjuvant BMS-813160, Nivolumab, Gemcitabine, and Nab-Paclitaxel for Patients with Pancreatic Cancer.Patrick M Grierson, Crystal Wolf, Rama Suresh
|Jun 06, 2024
Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers.Jeffrey A Klomp, Jennifer E Klomp, Clint A Stalnecker
|Oct 06, 2023
A Pilot Study of Paricalcitol plus Nanoliposomal Irinotecan and 5-FU/LV in Advanced Pancreatic Cancer Patients after Progression on Gemcitabine-Based Therapy.Patrick M Grierson, Rama Suresh, Benjamin Tan
|Aug 03, 2023
Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration.Gregory L Beatty, Devora Delman, Jiayi Yu
|Nov 25, 2022
Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Adenocarcinoma.Patrick M Grierson, Benjamin Tan, Katrina S Pedersen
|Oct 13, 2022
Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study.Andrea Wang-Gillam, Kian-Huat Lim, Robert McWilliams
Pageof 2
Frequent Collaborators
5 joint publications
Kian-Huat Lim
3 joint publications
Katrina S Pedersen
3 joint publications
Benjamin Tan
3 joint publications
Amberly Brown
3 joint publications
Nicholas Boice
3 joint publications
Rama Suresh
2 joint publications
David G DeNardo
2 joint publications
Nikolaos A Trikalinos
2 joint publications
Olivia Aranha
2 joint publications
Lee Ratner
